Karen P Alexander
Karen P Alexander
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial [0.03%]
一种剂量的艾多沙班在老年房颤患者中的疗效：ELDERCARE-AF随机临床试验的事后分析之三种年龄层患者的临床结果
Masaru Kuroda,Eiji Tamiya,Takahisa Nose et al.
Masaru Kuroda et al.
Importance: Long-term use of oral anticoagulants (OACs) is necessary for stroke prevention in patients with atrial fibrillation (AF). The effectiveness and safety of OACs in extremely older patients (ie, aged 80 years or ...
Clinical Trial
JAMA cardiology. 2022 Jun 1;7(6):583-590. DOI:10.1001/jamacardio.2022.0480 2022
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial [0.03%]
低剂量三联药物治疗与常规护理对照组中目标收缩压的达标时间分析：TRIUMPH随机临床试验的事后分析结果
Sonali R Gnanenthiran,Nelson Wang,Gian Luca Di Tanna et al.
Sonali R Gnanenthiran et al.
Importance: Cumulative exposure to high blood pressure (BP) is an adverse prognostic marker. Assessments of BP control over time, such as time at target, have been developed but assessments of the effects of BP-lowering i...
Randomized Controlled Trial
JAMA cardiology. 2022 Jun 1;7(6):645-650. DOI:10.1001/jamacardio.2022.0471 2022
Association of Myocardial Fibrosis and Stroke Volume by Cardiovascular Magnetic Resonance in Patients With Severe Aortic Stenosis With Outcome After Valve Replacement: The British Society of Cardiovascular Magnetic Resonance AS700 Study [0.03%]
英国心血管磁共振协会AS700研究：严重主动脉瓣狭窄患者行瓣膜置换术后的心肌纤维化和心输出量与预后的相关性研究心血管磁共振评估结果
George D Thornton,Tarique A Musa,Marzia Rigolli et al.
George D Thornton et al.
Importance: Low-flow severe aortic stenosis (AS) has higher mortality than severe AS with normal flow. The conventional definition of low-flow AS is an indexed stroke volume (SVi) by echocardiography less than 35 mL/m2. C...
Multicenter Study
JAMA cardiology. 2022 May 1;7(5):513-520. DOI:10.1001/jamacardio.2022.0340 2022
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial [0.03%]
TET2驱动的克隆性血细胞增多症与卡那奴单抗的治疗反应：CANTOS随机临床试验的探索性分析
Eric C Svensson,Aviv Madar,Catarina D Campbell et al.
Eric C Svensson et al.
Importance: Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of atherosclerotic cardiovascular disease, and mouse experiments suggest that CHIP related to Tet2 loss of function in m...
Randomized Controlled Trial
JAMA cardiology. 2022 May 1;7(5):521-528. DOI:10.1001/jamacardio.2022.0386 2022
My Grandfather's Blueprint [0.03%]
我祖父的设计图式
Keith Ranney Love
Keith Ranney Love
Lipoprotein(a), Menopausal Hormone Therapy, and Risk of Coronary Heart Disease in Postmenopausal Individuals [0.03%]
脂蛋白(a)、绝经期激素治疗与绝经后人群冠心病风险的关系
Michael C Honigberg,Mark Trinder,Pradeep Natarajan
Michael C Honigberg
This observational study examines whether hormone therapy use modifies the association of lipoprotein(a) with coronary heart disease.
Validating Deep Learning to Distinguish Takotsubo Syndrome From Acute Myocardial Infarction-Beware of Shortcuts, Human Supervision Required [0.03%]
验证深度学习区分应激性心肌病和急性心梗的能力——警惕捷径，仍需人工干预
Ramsey M Wehbe,James D Thomas
Ramsey M Wehbe
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy [0.03%]
射频导管消融术治疗药物难治性肥厚型梗阻性心肌病患者中的应用研究
Mengyao Zhou,Shengjun Ta,Rebecca T Hahn et al.
Mengyao Zhou et al.
Importance: Patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms and outflow gradients have limited nonsurgical treatment options. The feasibility of percutaneous intramyocardial septa...
Randomized Controlled Trial
JAMA cardiology. 2022 May 1;7(5):529-538. DOI:10.1001/jamacardio.2022.0259 2022
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers [0.03%]
β受体阻滞剂治疗儿茶酚胺敏感性多形性室速患者的预后分析
Andrea Mazzanti,Deni Kukavica,Alessandro Trancuccio et al.
Andrea Mazzanti et al.
Importance: Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) may experience life-threatening arrhythmic events (LTAEs) despite β-blocker treatment. Further complicating management, the role of i...